@forbes.it
@newsen.bsky.socialTop Employers in Europe Revealed in Fortune 100 Ranking for 2026 #London #United_Kingdom #AbbVie #FORTUNE_100 #Hilton_Worldwide
@pennadsb.comPlaneAlert ICAO: A70E5B
Owner: ABBVIE
Flt: N554AV GA6C
Time: 2026-10-07 17:22:03 EDT
Min Alt: 25500 ft
adsb planefence planealert by kx1t - sdr-e adsbexchange flightaware faa
@longevitytech.bsky.socialAbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the company says.
Link as first comment.
@newsen.bsky.socialAbbVie's Telisotuzumab Adizutecan Achieves FDA Breakthrough Designations for Cancer Treatments #United_States #AbbVie #North_Chicago #Telisotuzumab #Temab-A
@newsen.bsky.social@newsen.bsky.socialAbbVie Seeks EMA Approval for Subcutaneous Risankizumab in Crohn's Disease Treatment #United_States #Crohn's_Disease #AbbVie #North_Chicago #Risankizumab
@newsen.bsky.socialAbbVie and BioLabs Announce Winners of the Japan Innovation Award #Japan #Tokyo #AbbVie #BioLabs #Tuning_Fork_Bio
@newsen.bsky.socialPromising Phase 3 Results for Epcoritamab Combined with R-CHOP in DLBCL Treatment #USA #Epcoritamab #AbbVie #North_Chicago #DLBCL
@gmj-georgia.bsky.social🔬 Biotech M&A is roaring back. AbbVie's acquisition of Apogee Therapeutics signals renewed confidence in pharmaceutical deal-making after an extended slowdown. Recent Phas… #2026 #AbbVie #ApogeeTherapeutics #Biotech #Clinicaltrials #2026 #AbbVie #ApogeeTherapeutics #Biotech #Clinicaltrials htt…
@financiernews.bsky.social🏥 AbbVie Joins 340B Rebate Pilot With Amgen, Pfizer and GSK
ABBV trades at 262.82, up 1.11% today, as the drugmaker joins a federal 340B rebate pilot alongside Amgen, Pfizer and GSK.
@freegardener.bsky.socialAbbVie ships profitable medicines at scale while CRISPR bets on gene editing with no steady revenue. Two risk profiles that don't cancel out. #AbbVie #CRISPR #Biotech #Pharma
https://freegardner.com/sci_scout/abbvie-vs-crispr-therapeutics-pharma-comparison.html
@newsen.bsky.socialAbbVie Unveils Comprehensive RINVOQ® Data on Non-Segmental Vitiligo Treatment Progress #USA #AbbVie #North_Chicago #RINVOQ #Vitiligo
@newsen.bsky.socialAbbVie Strengthens Leadership in Migraine Treatments with Positive Atogepant Trial Results #United_States #AbbVie #North_Chicago #Atogepant #menstrual_migraine
@pharmaphorum.bsky.social#AbbVie's long-acting anti-IL-13 antibody #zumilokibart – the main asset in its $10.9 billion takeover of Apogee Therapeutics – has hit the mark in a phase 2b trial in #atopicdermatitis, its lead indication.
@aboveheerlen.bsky.socialPlaneAlert ICAO: A70E5B
Owner: ABBVIE
Flt: N554AV GA6C
Time: 2026-09-30 13:01:21 CEST
Min Alt: 32475 ft
Squawk: 0125
aircraft over heerlen - adsb planefence by kx1t - sdr-e airplanes flightaware faa
@abovefrl.bsky.socialPlaneAlert ICAO: A70E5B
Owner: ABBVIE
Flt: N554AV GA6C
Time: 2026-09-30 12:58:41 CEST
Min Alt: 8742 m
adsb planefence planealert by kx1t - sdr-e adsbexchange flightaware faa
@newsen.bsky.socialAbbVie Unveils Promising Phase 1 Results for Innovative Obesity Treatment at EASD 2026 #United_States #AbbVie #North_Chicago #ABBV-295 #EASD_2026
@newsen.bsky.socialAbbVie Presents Promising Phase 2 Results for Zumilokibart at EADV 2026 as a Late Breaker #United_States #AbbVie #North_Chicago #Zumilokibart #EADV
@newsen.bsky.socialAbbVie Presents Groundbreaking Dermatology Research Results at 2026 EADV Congress #United_States #dermatology #AbbVie #North_Chicago #EADV2026